Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Mahipal

Showing results (31-40 of 179) with videos related to

Pageof 18
Sort By:
World Journal of Gastrointestinal Oncology|September 4, 2020
Early stage colon cancer: Current treatment standards, evolving paradigms, and future directionsSakti Chakrabarti, Carrie Y Peterson, Deepika Sriram, et al.
Medical Oncology (Northwood, London, England)|January 26, 2011
Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinomaAmit Mahipal, Mary J Mcdonald, Agnieszka Witkiewicz, et al.
Journal of Gastrointestinal Oncology|January 10, 2024
Postpartum related intrahepatic cholangiocarcinoma with <i>FGFR2</i> fusion and severe hyperbilirubinemia with response to FGFR inhibitor pemigatinib: case report and reviewLeslie Washburn, Amit Mahipal, Aminah Jatoi, et al.
Journal of Gastrointestinal Cancer|May 29, 2015
A Meta-analysis of Randomized Clinical Trials of Chemoradiation Therapy in Locally Advanced Pancreatic CancerChenwi Ambe, William Fulp, Gregory Springett, et al.
Life (Basel, Switzerland)|October 28, 2023
Targeted Therapies in Advanced CholangiocarcinomaMichael H Storandt, Peter C Kurniali, Amit Mahipal, et al.
Cancers|July 9, 2022
Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)-Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC)Sakti Chakrabarti, Anup Kumar Kasi, Aparna R Parikh, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 18, 2024
Metabolism, toxicity and management of fruquintinib: a novel drug for metastatic colorectal cancerKanchi Patell, Veronica Lee Mears, Michael H Storandt, et al.
The Lancet. Oncology|January 8, 2020
Second-line therapies in advanced biliary tract cancersSri Harsha Tella, Anuhya Kommalapati, Mitesh J Borad, et al.
Cancers|January 28, 2026
Glucagon-like Peptide-1 Receptor Agonist Use and Pancreatic Cancer Risk in Patients with Chronic PancreatitisSarina Ailawadi, Jennifer E Murphy, Michael H Storandt, et al.
Expert Opinion on Investigational Drugs|August 21, 2018
Novel targeted treatment options for advanced cholangiocarcinomaAmit Mahipal, Anuhya Kommalapati, Sri Harsha Tella, et al.
Pageof 18

Showing results (31-40 of 179) with videos related to

Sort By:
Pageof 18
World Journal of Gastrointestinal Oncology|September 4, 2020
Early stage colon cancer: Current treatment standards, evolving paradigms, and future directionsSakti Chakrabarti, Carrie Y Peterson, Deepika Sriram, et al.
Medical Oncology (Northwood, London, England)|January 26, 2011
Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinomaAmit Mahipal, Mary J Mcdonald, Agnieszka Witkiewicz, et al.
Journal of Gastrointestinal Oncology|January 10, 2024
Postpartum related intrahepatic cholangiocarcinoma with <i>FGFR2</i> fusion and severe hyperbilirubinemia with response to FGFR inhibitor pemigatinib: case report and reviewLeslie Washburn, Amit Mahipal, Aminah Jatoi, et al.
Journal of Gastrointestinal Cancer|May 29, 2015
A Meta-analysis of Randomized Clinical Trials of Chemoradiation Therapy in Locally Advanced Pancreatic CancerChenwi Ambe, William Fulp, Gregory Springett, et al.
Life (Basel, Switzerland)|October 28, 2023
Targeted Therapies in Advanced CholangiocarcinomaMichael H Storandt, Peter C Kurniali, Amit Mahipal, et al.
Cancers|July 9, 2022
Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)-Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC)Sakti Chakrabarti, Anup Kumar Kasi, Aparna R Parikh, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 18, 2024
Metabolism, toxicity and management of fruquintinib: a novel drug for metastatic colorectal cancerKanchi Patell, Veronica Lee Mears, Michael H Storandt, et al.
The Lancet. Oncology|January 8, 2020
Second-line therapies in advanced biliary tract cancersSri Harsha Tella, Anuhya Kommalapati, Mitesh J Borad, et al.
Cancers|January 28, 2026
Glucagon-like Peptide-1 Receptor Agonist Use and Pancreatic Cancer Risk in Patients with Chronic PancreatitisSarina Ailawadi, Jennifer E Murphy, Michael H Storandt, et al.
Expert Opinion on Investigational Drugs|August 21, 2018
Novel targeted treatment options for advanced cholangiocarcinomaAmit Mahipal, Anuhya Kommalapati, Sri Harsha Tella, et al.
Pageof 18